T 0509/20 (Modified antibodies/CHUGAI) of 28.07.2022
- European Case Law Identifier
- ECLI:EP:BA:2022:T050920.20220728
- Date of decision
- 28 July 2022
- Case number
- T 0509/20
- Online on
- 8 September 2022
- Petition for review of
- -
- Application number
- 11714860.1
- IPC class
- C07K 16/00
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Antibodies with modified affinity to FcRn that promote antigen clearance
- Applicant name
- Chugai Seiyaku Kabushiki Kaisha
- Opponent name
- Ablynx N.V.
Alexion Pharmaceuticals, Inc.
Glaxo Group Limited
Murphy, Colm Damien
Shire Human Genetic Therapies, Inc.
Tillotts Pharma AG - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)
- Keywords
- Amendments - extension beyond the content of the application as filed (yes)
- Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.